Click the links below to find more information:

SOPH video/templatefiles/umc_video.aspx?id=2147548944Mannings for Health2016-04-25-01 $100 campaign for Children’s of Mississippi growth starts with $10 million gift from Sandersons
  • John T. Lam, MD

     lam, john t..jpgAssociate Professor
    Clinical Pathology
    Director, Hematopathology
    Phone: (601) 815-6253
    Fax: (601) 984-2885
    E-mail: jlam@umc.edu

    Education and Training

    • Tulane University School of Medicine, 1990
    • AP & CP Pathology, University of Alabama at Birmingham, 2000
    • Cancer gene therapy, University of Alabama at Birmingham, 2003
    • Hematopathology, University of Alabama at Birmingham, 2004

    Clinical interests

    • Diagnosis of hematopoietic diseases

    Dr. Lam is certified by American Board of Pathology in Clinical Pathology and Hematopathology. He specializes in hematopathology pathology.

    Research interests

    • Biomarkers for diagnosis, prognosis, and treatment of neoplastic diseases

    The focus of Dr. Lam's research is JAK2 as a marker for neoplastic diseases.

    • Memberships: College of American Pathologists, American Society for Clinical Pathology
    • Committee positions: member, Cancer Center Protocol Review Committee
      Institutional positions: Course Director for UMMC School of Medicine courses Pathology 631 and 652 (third- and fourth-year medical student clinical pathology electives, respectively)

    Recent publications and presentations

    • “A leukemia/lymphoma with lymphoblastic morphology and L3 morphologic relapse.” Lam JT, Jackson CC, Cruse JM, Young-Gaylor LD. Pediatr Hematol Oncol. 2011 Sep;28(6):523-5.
    • “Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML.”, Cruse JM, Lewis RE, Sanders CM, Webb RN, Beason KL, Lam J, Koehler J. Exp Mol Pathol. 2007 Jun 23.